Stocks股票 / Health Care / IQV
IQV US listed · USD美股 · 美元
IQVIA Holdings, Inc. is an American health information technology and clinical research company headquartered in Durham, North Carolina.IQVIA控股公司是一家美国健康信息技术和临床研究公司,总部位于北卡罗来纳州达勒姆。
Company news公司新闻
The latest reporting最新报道
One story, with the reporting behind it.将同一事件汇总,保留各来源报道。
The latest call, in context把最新财报放回历史脉络
A synthesized event record across management commentary and recorded metrics. Read as context; verify exact wording in the transcript before relying.综合管理层表述与记录指标形成事件档案。仅供参考;使用前请在电话会原文中核对准确措辞。
Live company record实时公司记录
JavaScript loads the source-bounded event record here. Open Terminal if the live module does not start.JavaScript 会在此加载受来源约束的事件记录。如实时模块未启动,请打开终端。
Continue with full transcript history继续查看完整电话会历史 ↗Price chart价格图表
Technicals技术面
daily bars日线数据 · 2026-10-26Earnings财务业绩
next report下次财报 2026-10-27Estimates being cut预期下调
Beat expectations 4 quarters in a row连续 4 季度超预期
EPS surprise vs consensus, last quarters每股收益相对预期的超预期幅度(近几个季度) · average平均 2.9%
Valuation估值
Roughly fair vs sector相对行业估值合理| Multiple指标 | IQV | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| P/E (trailing)市盈率(历史) | 34.84x | 31.50 | |
| P/B市净率 | 7.29x | 3.57 | |
| P/S市销率 | 2.90x | 3.19 | |
| Earnings yield盈利收益率 | 2.87% | 2.37 | |
| FCF yield自由现金流收益率 | 4.33% | 3.88 | |
| Shareholder yield股东收益率 | 2.63% | 1.83 | |
| EV/EBITDA企业价值/EBITDA | 18.38x | 19.32 | |
| P/FCF市值/自由现金流 | 23.10x | 23.56 |
Financials财务数据
fiscal years财年Leverage杠杆
Capital allocation资本配置
Debt coming due到期债务
FY2025 10-KIn the 12-month bucket following fiscal period end 2025-12-31, it reported $1.8B due — about 12% of its disclosed principal.在财年期末 2025-12-31 之后12个月的区间内,已披露到期本金为 $1.8B,约占其披露本金的 12%。
All maturity buckets are measured from fiscal period end 2025-12-31, not from today.所有到期区间均从财年期末 2025-12-31 起算,而非从今天起算。
A cash-flow scenario is unavailable until the filing inputs are verified.报告数据核实前,现金流情景暂不可用。
Capital-need coverage is partial; incomplete or incompatible filing inputs are not combined.资本需求覆盖信息不完整;不会合并不完整或不兼容的报告数据。
Any available cash-flow scenario is context only. Missing or incompatible inputs are not replaced with zero or a financing forecast.可用现金流情景仅供参考;缺失或不兼容的输入不以零值或融资预测替代。
Sources and cash-flow calculation来源与现金流计算
Figures are XBRL facts from one filing — no two years are mixed. Filing数据取自同一份文件中的 XBRL 事实,不跨文件拼接。文件
0001628280-26-008322, period ending报告期截至 2025-12-31, unit单位 USD.
Cache acquired缓存获取时间: 2026-09-26T08:04:40.209266+00:00.
6/6 buckets reported.个区间有披露。
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonthsLongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwoLongTermDebtMaturitiesRepaymentsOfPrincipalInYearThreeLongTermDebtMaturitiesRepaymentsOfPrincipalInYearFourLongTermDebtMaturitiesRepaymentsOfPrincipalInYearFiveLongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
Why is it moving为何波动
6 checks · nightly六项检查 · 每晚Options positioning期权持仓
as of last close截至上一收盘Market makers are net long gamma — price pinned near current level做市商净持有正伽玛,价格倾向于在当前水平附近震荡
Ownership & smart money持仓与聪明钱
13FInsider activity:内部人动向: -$29.9M net (0 buyers, 6 sellers)-$29.9M 净值(0 买家,6 卖家)
Signal history信号历史
engine events引擎事件Company profile公司档案
IQVIA Holdings, Inc. is an American health information technology and clinical research company headquartered in Durham, North Carolina.IQVIA控股公司是一家美国健康信息技术和临床研究公司,总部位于北卡罗来纳州达勒姆。
Demand chain:需求链: Contracted bookings (RPO) flat (+2% YoY to ~$34B, 2.1× revenue) — signed demand locked in ahead of recognition已签约订单(RPO)持平(同比+2%,约 $34B,覆盖营收 2.1 倍)——已锁定、尚未确认的需求
The whole US universe — S&P 1500 and Russell 2000 — read nightly.覆盖标普1500与罗素2000全部成分股 — 每晚更新解读。
Signals, options positioning, smart-money moves and factor DNA — the same engine that wrote this page covers 2,700+ US stocks.信号、期权持仓、聪明钱动向与因子基因 — 撰写本页的引擎覆盖2700多只美股。
Valuation vs sector估值对比行业
| Multiple指标 | This stock本股 | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| P/E (trailing)市盈率(静态) | 34.8× | 31.5× | 43% |
| Price / Book市净率 | 7.3× | 3.6× | 21% |
| Price / Sales市销率 | 2.9× | 3.2× | 54% |
| EV / EBITDAEV/EBITDA | 18.4× | 19.3× | 56% |
| Earnings yield盈利收益率 | 2.9% | 2.4% | 57% |
| Free-cash-flow yield自由现金流收益率 | 5.6% | 5.2% | 62% |
| Shareholder yield股东综合回报率 | 2.6% | 1.8% | 63% |
Relative strength相对强度
Price history价格历史
| Period周期 | This stock本股 | S&P 500标普500 |
|---|---|---|
| 1 Week近1周 | +4.7% | -0.4% |
| 1 Month近1月 | +4.3% | -1.0% |
| 3 Months近3月 | +34.3% | +3.1% |
| 6 Months近6月 | +72.1% | +7.0% |
| Year to date年初至今 | +24.0% | +12.1% |
| 1 Year近1年 | +27.0% | +14.4% |
Trading information交易信息
Multi-year record多年财务记录
| 20202020 | 20212021 | 20222022 | 20232023 | 20242024 | 20252025 | |
|---|---|---|---|---|---|---|
| Revenue营业收入 | $11.4B | $13.9B | $14.4B | $15.0B | $15.4B | $16.3B |
| EPS每股收益 | $1.43 | $4.95 | $5.72 | $7.29 | $7.49 | $7.84 |
| Free cash flow自由现金流 | $1.3B | $2.3B | $1.6B | $1.5B | $2.1B | $2.1B |
| Gross margin毛利率 | — | — | — | — | — | — |
| Net margin净利率 | 2.5% | 7.0% | 7.6% | 9.1% | 8.9% | 8.3% |
| FCF margin自由现金流利润率 | 11.8% | 16.6% | 11.0% | 10.0% | 13.7% | 12.6% |
Latest fiscal year最近财年
Returns & growth回报与增长
Accounting quality checks会计质量检查
- Earnings quality: accruals near the peer median盈利质量:应计利润接近同业中位
- Working capital: working capital roughly in line with sales营运资本:营运资本与销售大致同步
- Capital discipline: investment near the peer median资本纪律:投资力度接近同业中位
- Balance sheet: Altman Z 2.27 — grey zone资产负债表:Altman Z 2.27——灰色区
Indicator readings指标读数
Timeframe alignment多周期共振
Volatility regime波动状态
Surprise history超预期历史
| Quarter季度 | Reported实际 | Expected预期 | Surprise超预期 |
|---|---|---|---|
| Jun 2026 | $2.75 | $2.72 | +1.1% |
| Mar 2026 | $2.64 | $2.51 | +5.2% |
| Dec 2025 | $3.24 | $3.13 | +3.5% |
| Sep 2025 | $2.73 | $2.68 | +1.9% |